Yang-Dan-Tang, Identified from 15 Chinese Herbal Formulae, Inhibits Human Lung Cancer Cell Proliferation via Cell Cycle Arrest by Wang, Tien-Chun et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 276032, 12 pages
doi:10.1155/2012/276032
Research Article
Yang-Dan-Tang, Identiﬁedfrom15 Chinese Herbal
Formulae,InhibitsHuman Lung Cancer Cell Proliferation via
Cell Cycle Arrest
Tien-Chun Wang,1 Chih-Nan Fang,2 Chih-Chien Shen,1 Hui-YuWei,1 Yui-PingWeng,3
Jung-YawLin,4 HsiuMei Hsieh-Li,1 andChen-Yu Lee5
1Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan
2Kuo-Hsing Chinese Clinic, Taipei 110, Taiwan
3Department of Biological Science and Technology, Chung Hwa University of Medical Technology, Tainan 717, Taiwan
4Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
5Yu-Sheng Chinese Clinic, Taipei 106, Taiwan
Correspondence should be addressed to Hsiu Mei Hsieh-Li, hmhsieh@ntnu.edu.tw and Chen-Yu Lee, chenyr.lee@msa.hinet.net
Received 16 November 2011; Revised 29 February 2012; Accepted 26 March 2012
Academic Editor: Richard Pietras
Copyright © 2012 Tien-Chun Wang et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Lung cancer has long been one of the most deadly forms of cancer. The majority of lung cancers are of the non-small-cell lung
cancer (NSCLC) type. Here we used the non-small-cell lung carcinoma cell line A549 to screen 15 diﬀerent traditional Chinese
herbalmedicine(CHM)formulaetoexplorethepossiblemechanismsofalternativemedicineinlungcancertherapy.Weidentiﬁed
three formulae (Formulae 3, 5, and 14) that substantially decreased the survival of A549 cells but did not aﬀect MRC5 normal
lung tissue cells. Formula 14, Yang-Dan-Tang, a modiﬁed decoction of Ramulus Cinnamomi Cassiae, was chosen for further
characterization. Flow cytometry analysis showed that treatment of Formula 14 induced cell cycle arrest in G1 and G2 phase
without causing signiﬁcant cell death. These results were also conﬁrmed by Western blot analysis, with decreased expression of
G1/S and G2/M promoting cell cycle machinery including cyclin D3, cyclin B1, CDK4, and CDK6. This study provides further
insight into the possible working mechanism of Yang-Dan-Tang in patients.
1.Introduction
Lung cancer, with high incidence and mortality, has long
been the most deadly cancer disease. Most lung cancers
are carcinomas, and non-small-cell lung carcinoma accounts
for more than 80% of these [1]. Although there are
many therapeutic approaches toward cancer, none of the
treatments can yet substantially cure cancer patients. The
development of new drugs and therapies is therefore still of
great urgency.
Chinese herbal medicine (CHM) has been used to
treat lung cancers for centuries in East Asia. CHM is the
most important therapeutic modality of traditional Chinese
medicine (TCM). There are more than 130 CHMs that have
been reported to have anti-lung-cancer ability [2]a n da b o u t
40 CHMs [3] and 30 formulae have been frequently used
f o rl u n gc a n c e rp a t i e n t s[ 4]. CHMs are usually applied to
patients in a form of formula, and each formula may contain
more than three herbs. Generally there are one or two major
ingredients toward the disease therapy and other ingredients
were used to adjust the yin yang extent of the formula
according to the patient’s status [5, 6]. Some of CHMs are
alsousedinpatientsunderchemotherapiesorradiotherapies
to reinforce patients’ immune activity and metabolism for
improving overall prognosis [7, 8]. Although the use of
CHMs as therapeutic approaches is very common in East
Asia,thespeciﬁcmechanismsofhowCHMsaﬀectthedisease
still remain largely unknown.
Many studies have used A549 NSCLC lung cancer cells
to evaluate the eﬀects of herbs and herb constituents on2 Evidence-Based Complementary and Alternative Medicine
lung cancers. Plumbagin, phenylbutenoid, and parthenolide
were demonstrated to inhibit proliferation of A549 cells
[9–11], cantharidin, curcumin, and gambogic acid were
reported to induce apoptosis of A549 cells [12–14], and
ginsenoside was suggested to have antimetastatic potential
toward A549 cells [15]. However, most studies focused on
the eﬀects of one single herb toward cancer cells, but not the
prescribed multiple herb formula which patients normally
take. In this study, we used A549 cells as an NSCLC model
to test 15 diﬀerent CHM formulae which are considered by
TCM physicians to have some potential in treating cancers
(Table 1).
2.MaterialsandMethods
2.1. Cell Culture and Herbal Formula Preparation. The
NSCLC cell lines A549 (carcinoma), NCI-H460 (H460,
large cell carcinoma), and NCI-H520 (H520, squamous cell
carcinoma) and the normal cell line MRC5 were purchased
from Bioresource Collection and Research Center (BCRC,
Taiwan) and cultured with F12K (for A549), RPMI1640 (for
both H460 and H520), and MEM (for MRC5) medium
containing 10% FBS, respectively, in a 37◦C, 5% CO2
incubator. MRC5 cells are normal fetal lung ﬁbroblast cells
and used as noncancerous cells in many in vitro lung cancer
cytotoxicity studies [16–18].The15diﬀerentCHMformulae
(Table 1) were used to prepare the herbal decoctions as
normally prescribed by a CHM doctor for patients. The
herbs were boiled in 1.2 L of water for 1hr to generate the
ﬁnal decoction (around 450mL), and aliquots were stored at
4◦C. To prevent instability and unequal recovery of diﬀerent
ingredients of each formula, concentration under vacuum
evaporator was not conducted for all these 15 decoctions.
Each formula was applied to cell cultures after decoction
debris was removed by passing the liquid through a 0.22µm
membrane ﬁlter.
2.2. Cell Proliferation Assay. Three diﬀerent concentrations
of the 15 formula decoctions, 1%, 2%, and 10% (v/v),
were applied to A549 cells to determine the IC50 of
each formula. The maximum 10% decoction was used
to avoid dilution of the medium by a large volume of
decoction. A549 cells were seeded at 1 × 104 cells per
well in a 24-well plate to ensure cells grow logarithmically
during total treatment period. Diﬀerent decoctions were
added to the cells 24hr after seeding, and cell growth
was determined by MTT assays after cells were treated for
72hr.
To test the nontarget eﬀects, IC50 of the eight formulae
toward A549 (F3: 4%, F4: 8.4%, F5: 2.2%, F6: 9%, F8: 0.4%,
F9:4.2%,F14:7%,F15:4%)wereappliedtoA549andMRC5
cells at the same time. Cell growth was examined by MTT
assay after a 72 hr treatment. For time course studies, 7%
(v/v) of Formula 14 was applied to A549 cells and MTT assay
was performed with these cells after treatment for 0, 24, 48,
and 72hr, respectively. For H460 and H520 cell lines, diﬀer-
ent amounts of Formula 14 (2–10%) were applied for MTT
assay.
2.3. Apoptosis Analysis. Characterization of the apoptosis
status of A549 cells after Formula 14 (7%) treatment was
performed with annexin-V-FLUOS Staining Kit (Roche,
Mannheim, Germany) according to the protocol provided
by manufacturer. Brieﬂy, 1 × 105 A549 cells were seeded
on one 6 cm plate. After treatment for 72hr, cells were
harvested and resuspended with prediluted staining buﬀer
(Annexin-V-Fluos labeling reagent, propidium iodide, and
incubation buﬀer 1:1:50, resp., 100µLf o r1× 106 cells).
After incubation for 15min in the dark and sieving through
35µm nylon mesh, cells were analyzed using FACSCalibur
(BD Biosciences, San Jose, CA, USA).
2.4. Colony-Forming Assay. The colony-forming assay was
modiﬁed from previous studies [19, 20]. In brief, A549 and
H460 cells treated with Formula 14 (7% and 4.3%, resp.) or
vehicle for 72hr were harvested and seeded onto a 6-cm dish
(500 cells) and cultured in a 37◦C, 5% CO2 incubator for
14 days. The dishes were then removed from the incubator
and the medium was discarded. After washing with PBS, the
cellswereﬁxedwithcoldmethanolfor10min.Theﬁxedcells
were then stained with crystal violet (Sigma, St. Louis, MO,
USA) for 3min at room temperature. The number of cell
colonies in the central 12.25cm2 of the dishes was counted
to represent the colony-forming ability of the cells.
2.5. Soft Agar Assay. Bacto agar (1.8%) and 2 × F12K/
DMEM were mixed (1:1) and used to coat the base of a
6-well plate to form a 0.9% agar base. A549 cells treated
w i t hF o r m u l a1 4( 7 % )o rv e h i c l ef o r7 2 h rw e r eh a r v e s t e d
and 1000 cells were mixed with 1.3% methylcellulose and
2 × F12K/DMEM (1:1) and seeded onto the 0.9% agar
plate. The cells were then incubated at 37◦C, 5% CO2 in
an incubator for one month. Cell colonies in the central
6.5cm2 of the plates were directly counted under microscope
to represent the colony-forming ability of cells on soft agar.
2.6. Cell Cycle Analysis. A549 cells were seeded at a density
of 1 × 105 cells on 6cm plates, and Formula 14 (7%)
was applied to the cells after culture for 24hr. Cells were
incubated for diﬀerent time periods then ﬁxed with 70%
EtOH and stained with propidium iodide for 30min at
37◦C in the dark with frequent shaking. Cells were sieved
through a 35µm nylon mesh and immediately analyzed
using FACSCalibur. The percentages of cells at diﬀerent cell
cycle phases were calculated with ModFit software (Verity,
Software House, Topsham, ME, USA).
2.7.Ki67Analysis. After treatment with Formula 14 (7%) for
72hr, cells were ﬁxed and stained with Ki67 antibody and PI
using the PE Mouse Anti-Human Ki-67 Set (BD Pharmin-
gen) according to the manufacturer’s instruction, with slight
modiﬁcation. Nonspeciﬁc PE-conjugated isotype antibody
was used as control in this analysis. Both nonstained and
single-stained groups were included in the ﬂuorescence
compensation. All samples were ﬁltered through 35µm
nylon mesh before entering the ﬂow cytometer (LSR II, BDEvidence-Based Complementary and Alternative Medicine 3
Table 1: The composition of 15 herbal formulae.
Formula 1
Angelicae Sinensis 11.25g, Ligustici Chuanxiong 11.25g, Paeoniae Rubrae 11.25g, Rehmanniae
Glutinosae 11.25g, Gummi Olibanum 11.25g, Myrrha 11.25g, Atractylodis Rhizoma 11.25g,
Raw Radix Glycyrrhizae Uralensis 11.25g, Semen Persicae 11.25g, Flos Carthami Tinctorii 1.875g
Formula 2 Angelicae Sinensis 11.25g, Ligustici Chuanxiong 11.25g, Paeoniae Rubrae 11.25g, Rehmanniae
Glutinosae 11.25g
Formula 3
Rhizoma Coptidis 11.25g, Radix Scutellariae Baicalensis 11.25g, Cortex Phellodendri 11.25g,
Fructus Gardeniae Jasminoidis 11.25g, Raw Radix Glycyrrhizae Uralensis 18.75g, Atractylodis
Rhizoma 15g
Formula 4
Radix Gentianae Longdancao 11.25g, Radix Scutellariae Baicalensis 11.25g, Fructus Gardeniae
Jasminoidis 7.5g, Angelicae Sinensis 11.25g, Rehmanniae Glutinosae 11.25g, Caulis Mutong
11.25g, Radix Bupleuri 11.25g, Semen Plantaginis 11.25g, Atractylodis Rhizoma 15g, Rhizoma
Alismatis Orientalis 15g, Raw Radix Glycyrrhizae Uralensis 18.75g
Formula 5 Rhizoma Coptidis 11.25g, Rhizoma Cimicifugae 11.25g, Angelicae Sinensis 11.25g, Rehmanniae
Glutinosae 11.25g, Cortex Moutan Radicis 11.25g
Formula 6
Fructus Forsythiae Suspensae 11.25g, Herba Menthae Haplocalycis 11.25g, Fructus Gardeniae
Jasminoidis 11.25g, Radix Scutellariae Baicalensis 11.25g, Herba Lophatheri Gracilis 11.25g,
Raw Radix Glycyrrhizae Uralensis 11.25g, Radix et Rhizoma Rhei 3.75g, Mirabilitum 3.75g,
Atractylodis Rhizoma 15g
Formula 7
Pericarpium Citri Reticulatae 15g, Rhizoma Pinelliae Ternatae 15g, Sclerotium Poriae Cocos
15g, Raw Radix Glycyrrhizae Uralensis 15g, Radix Scutellariae Baicalensis 11.25g, Fructus
Immaturus Citri Aurantii 11.25g, Caulis Bambusae in Taeniis 3ea, Fructus Zizyphi Jujubae 5ea
Formula 8
Angelicae Sinensis 11.25g, Ligustici Chuanxiong 11.25g, Paeoniae Rubrae 11.25g,Rehmanniae
Glutinosae 11.25g, Radix Glycyrrhizae Uralensis 11.25g, Radix Scutellariae Baicalensis 11.25g,
Cortex Lycii Radicis 18.75g, Cortex Moutan Radicis 18.75g, Atractylodis Rhizoma 15g
Formula 9
Angelicae Sinensis 11.25g, Ligustici Chuanxiong 11.25g, Radix Paeoniae Lactiﬂorae 11.25g,
Rehmanniae Glutinosae 11.25g, Fried Atractylodis Macrocephalae 11.25g, Radix Glycyrrhizae
Uralensis 11.25g, Radix Dipsaci Asperi 11.25g, Cortex Eucommiae Ulmoidis 11.25g, Radix
Scutellariae Baicalensis 11.25g, Radix Dioscoreae Oppositae 18.75g, Folium Artemisiae Argyi
18.75g
Formula 10 Radix Achyranthis Bidentatae 30g, Radix Dipsaci Asperi 30g, Rhizoma Drynariae 30g,
Rubiaakane Nakai 30g, Raw Radix Glycyrrhizae Uralensis 18.75g, Atractylodis Rhizoma 15g
Formula 11 Angelicae Sinensis 30g, Radix Polygoni Multiﬂori 30g, Semen Cuscutae Chinensis 30g, Semen
Astragali Complanati 30g, Tribulus terrestris Linn 15g, Atractylodis Rhizoma 15g
Formula 12
Angelicae Sinensis 11.25g, Ligustici Chuanxiong 11.25g, Paeoniae Rubrae 7.5g, Rehmanniae
Glutinosae 11.25g, Radix Salviae Miltiorrhizae 18.75g, Atractylodis Rhizoma 18.75g, Radix
Astragali Membranacei 56.25g
Formula 13 Radix Astragali Membranacei 75g, Angelicae Sinensis 15g, Ligustici Chuanxiong 15g, Paeoniae
Rubrae 15g, Ginkgo Bilobae 15g
Formula 14
Ramulus Cinnamomi Cassiae 18.75g, Paeoniae Rubrae 18.75g, Raw Radix Glycyrrhizae
Uralensis 18.75g, Rhizoma Zingiberis Oﬃcinalis Recens 18.75g, Radix Scutellariae Baicalensis
11.25g, Fructus Zizyphi Jujubae 5ea
Formula 15 Rhizoma Cimicifugae 7.5g, Rehmanniae Glutinosae 56.25g, Paeoniae Rubrae 37.5g, Cortex
Moutan Radicis 37.5g, Radix Scutellariae Baicalensis 37.5g
Biosciences). The data were analyzed with FlowJo software
(TreeStar, Ashland, OR, USA).
2.8. Western Blot Analysis. Molecules involved in cell cycle
regulation were examined using Western blot analyses. A549,
H460, and H520 cells were seeded at 2 × 105,7× 104,a n d
5 × 105 cells, respectively, on 10 cm plates and harvested
after treatment for 72hr. Cells were lysed with RIPA buﬀer
(100mM Tris pH 7.5, 50mM NaCl, 5mM EDTA pH 8.0, 1%
SDS, 1% sodium deoxycholate, 1% NP40). Ten µgp r o t e i n
of each sample was electrophoresed by SDS-PAGE and then
transferred onto Hybond-C extra membrane (Amersham,
GE Healthcare, UK). The membrane was blocked with 5%
nonfat dry milk powder in Tris-buﬀered saline with 0.1%
Tween-20 for 1hr at room temperature. After blocking,
the membrane was incubated with the primary antibody
[Cyclin D3, 1:1000; CDK4, 1:1000; CDK6, 1:1000; cdc2,
1:1000; pcdc2, 1:1000 and pRb,1:1000 (Cell Signaling,
Danvers,MA,USA);cyclinB1,1:1000(Upstate,LakePlacid,
NY, USA)]. The corresponding HRP-conjugated secondary4 Evidence-Based Complementary and Alternative Medicine
Table 2: Cytotoxicity of 15 CHM formulae against A549 cells.
Formula (v/v) 1% 2% 10% IC50 conc.
Formula 1 111% 98% 77% NA
Formula 2 106% 109% 95% NA
Formula 3∗ 67% 60% 32% 4%
Formula 4∗ 96% 96% 35% 8.4%
Formula 5∗ 57% 46% 28% 2.2%
Formula 6∗ 89% 83% 29% 9%
Formula 7 105% 106% 61% NA
Formula 8∗ 24% 11% 5% 0.4%
Formula 9∗ 107% 80% 7% 4.2%
Formula 10 104% 86% 51% NA
Formula 11 83% 87% 65% NA
Formula 12 94% 95% 69% NA
Formula 13 104% 102% 62% NA
Formula 14∗ 97% 77% 41% 7%
Formula 15∗ 76% 70% 12% 4%
∗Indicates the proliferation inhibition exceeds 50% under the maximum
dose.
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Figure 1: Eﬀect of 8 CHM formulae on the cytotoxicity of A549
cells. Survival rate of A549 and MRC5 cells following treatment at
the IC50 with the 8 chosen formulae for 72hr was analyzed by MTT
assay. Data were normalized to control groups. Formulae 3, 5, and
14 decreased the survival rate of A549 cells around 50% without
aﬀecting that of MRC5 cells.
antibody was applied to the membrane for 1hr to highlight
the speciﬁc signal. HRP substrate (Millipore, MA. USA)
was added onto blot membrane to show the hybridization
pattern,and imageswereacquiredwithimaging systemLAS-
3000 (Fujiﬁlm, Japan). Blot images were quantiﬁed with
Multi-Gauge software (Fujiﬁlm).
2.9. Statistical Analysis. Data are presented as mean ±
SE. Student’s t-test was performed with SPSS software to
evaluatethesigniﬁcanceofdiﬀerencesbetweengroupmeans.
A P-value of less than 0.05 was considered to be signiﬁcant.
3. Results
3.1. Cytotoxicity Analysis of 15 TCM Formulae. MTT assays
were performed with the NSCLC cell line A549 after treat-
ment with diﬀerent formulae for 72hr. Of the 15 formulae,
Formulae 3, 4, 5, 6, 8, 9, 14, and 15, substantially reduced the
growth rate of A549 cells over 50% at the highest 10% (v/v)
dosage (Table 2). The IC50 of the 8 formulae were calculated
using the interpolation method and are listed in Table 2.
Among these 8 formulae, Radix Scutellariae Baicalensis is
one of the dominant ingredients in 7 of them, except for
Formula5.RadixScutellariaeBaicalensisisalsoaningredient
of Formula 7 although 10% (v/v) reduced cell viability to
61%. Whether Radix Scutellariae Baicalensis is the major
component that decreases the growth of cells needs further
investigation.
To test whether these 8 active formulae have any signif-
icant nontarget eﬀect, the normal lung cell line MRC5 was
included in the cytotoxicity screening. The eight formulae
were used to treat A549 and MRC5 cell lines for 72hr at
their IC50 toward A549. We found that Formulae 3, 5, and 14
reduced the growth rate of A549 cells around 50% without
signiﬁcantly aﬀecting the viability of MRC5 cells (Figure 1).
In contrast, the other 5 formulae (4, 6, 8, 9, and 15) showed
signiﬁcant nontarget eﬀects, suppressing the growth rate of
MRC5 about 20–70% (Figure 1). Among the three A549-
speciﬁc formulae, Formula 14, Yang-Dan-Tang, a modiﬁed
decoction of Ramulus Cinnamomi Cassiae, was chosen for
further study due to its traditional CHM use as therapy for
lung disease.
3.2. CHM Formula 14 Reduced A549 Cells Proliferation
without Inducing Massive Apoptosis. To further elucidate the
growth inhibiting mechanisms of Formula 14, the time
course of the response of A549 cells to Formula 14 treatment
was examined. Formula 14 could signiﬁcantly decreased
the A549 cell numbers after 24hr treatment (Figure 2(a)),
suggesting that Formula 14 could either actually kill the cells
or inhibit the proliferation of the cells. The cell density of
the Formula 14 treated group was much lower than that of
control group; however, few dead cells could be seen under
microscope observation (Figure 2(b)).
To further clarify the two possibilities, Annexin V and
propidium iodide double staining was performed to see if
cell death occurred after treatment. No signiﬁcant diﬀerence
was identiﬁed for the healthy populations between Formula
14-treated and control groups (Figures 2(c) and 2(d)). In
addition, little cell death (early apoptosis, late apoptosis,
or necrosis) was identiﬁed in both the Formula 14-treated
and control groups (Figure 2(c)). These results suggest that
Formula 14 treatment reduction of the cell number might be
through inhibition of proliferation.
3.3. Eﬀects of CHM Formula 14 on the Decrease of A549 Cell
Colony Formation. We also conducted colony forming-assayEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: CHM Formula 14 decreased A549 cell survival without apparent apoptosis. A time course MTT assay was used to investigate
the response of A549 cells to treatment with Formula 14. (a) Formula 14 treatment signiﬁcantly inhibited the proliferation of A549 cells
at all the time points studied. (b) Bright ﬁeld images of A549 cells after 72hr treatment with vehicle or Formula 14. The cell density of
A549 cells after treatment with Formula 14 was much lower than the control group. (c) Representative data of annexin V and PI double
staining show the apoptosis/necrosis status of A549 cells after 72hr treatment with Formula 14. (d) Percentages of the double negative live
cells (bottom left square) were quantiﬁed to compare the healthy population. Formula 14 has no eﬀect on the live cell percentage. Student’s
t-test:,∗∗∗P<0.001.
to determine whether Formula 14 could aﬀect the tumori-
genesis ability of A549 cells, and the results showed that
the number of colonies at 14-day culture was signiﬁcantly
reducedincellspretreatedwithFormula14comparedtothat
of the control group (Figures 3(a) and 3(b)). In addition,
the formation of colonies on soft agar after one month
was also dramatically decreased in the Formula 14-treated
cells (Figure 3(c)). These two diﬀerent assays revealed that
Formula 14 could reduce tumorigenesis in A549 cells.
3.4. CHM Formula 14 Induced A549 Cell Cycle Arrest at
G1 and G2 Phases. We then tested whether Formula 14
aﬀectedcellcycleprogression,andtheresultsshowedthatthe
number of cells in the proliferative S phase was signiﬁcantly
decreased whereas cell populations in G1 and G2 phases
were signiﬁcantly increased after 24 and 72 hr treatment,
respectively (Figures 4(a) and 4(b)). However, there was no
cell population identiﬁed in the subG1 phase (Figure 4(a)).
These data indicate that CHM Formula 14 treatment did
notinducecellapoptosisbutratherreducedtheproliferation
rate of A549 cells. In addition, a Ki67 analysis showed there
were more cells in the quiescent G0 phase after treatment
with Formula 14, compared to that of the control group
(Figures 4(c) and 4(d)). In conclusion, CHM Formula 14
retarded cell cycle progression signiﬁcantly.
3.5. Eﬀect of CHM Formula 14 on the Expression Level of Cell
Cycle Related Genes. Wethenexaminedtheexpressionofcell
cycle regulatory proteins to uncover more molecular clues
to the eﬀects of Formula 14. Western blot analyses showed
that expression of G1/S transition promoting proteins,
including cyclin D3, D-type-cyclin-dependent kinase CDK4
and CDK6, and phosphorylated retinoblastoma protein
(pRb), the substrate of cyclin D/CDK4/6 complex, was
decreased by Formula 14 (Figure 5(a)). The reduced levels
of these molecules could result in G1 phase arrest, which
is in agreement with the result of the previous cell cycle
analysis. In addition to the G1 phase arrest, the G2 phase
cell population was also increased in A549 cells after
treatment with Formula 14 for 72hr (Figure 3(a)). We thus
further checked the G2/M transition regulating proteins,
cyclin B1 and cdc2 (cdk1). Treatment with Formula 146 Evidence-Based Complementary and Alternative Medicine
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Figure 3: CHM Formula 14 decreased the colony formation activity of A549 cells. (a) Cell colonies were stained with crystal violet
and scanned to generate images. Colony numbers of those cells treated with Formula 14 (lower panel) were signiﬁcantly decreased. (b)
Anchorage-independent growth ability. Colony numbers were signiﬁcantly decreased by treatment with Formula 14 for 72hr. Student’s
t-test: ∗, ∗∗∗P<0.05 and 0.001, respectively.
decreased the expression of both cyclin B1 and phosphory-
lated cdc2 (Tyr15-p-cdc2) and increased the total amount
of all forms of cdc2 (Figure 5(b)). The downregulation
of cyclin B1 is in accordance with the G2 arrest eﬀect
of Formula 14, while the decreased ratio of Tyr15-p-
cdc2/total cdc2 may result from the mixed composition of
Formula 14.
3.6. Formula 14 Has Similar Eﬀects on Other NSCLC Cell
Lines. To examine whether Formula 14 has similar cytotoxi-
city toward other NSCLC cells, we further applied Formula
on H460 (large cell carcinoma) and H520 (squamous cell
carcinoma) cell lines. Our results showed that Formula 14
also reduced the proliferation of both H460 and H520 cells
(Figures 6(a) and 6(b)). The IC50 for H460 and H520 are
4.5% and 3.8%, respectively. In addition, Formula 14 also
reduced the colony-forming activity of H460 cell line. The
number of colonies at 14-day H460 culture was signiﬁcantly
reducedincellspretreatedwithFormula14comparedtothat
of the control group (Figure 6(c)). The Western blot analyses
showed that Formula 14 decreased the expression levels of
cell cycle regulatory proteins, CDK4, pRb, and cyclin B1 of
H520cellline(Figure 6(d)).ThesedatashowedthatFormula
14 has a general eﬀect on diﬀerent NSCLC cell lines.
4. Discussion
In this study, we used the A549 cell line as an NSCLC model
to screen 15 diﬀerent CHM formulae (Table 1). Some of
the 15 formulae are frequently prescribed to cancer patients
while the others were considered by TCM physicians to have
somepotentialintreatingcancers.Formulae3,5and14were
identiﬁedtosubstantiallyreducethegrowthofA549cellsbut
not MRC5 normal lung tissue cells. Formula 14 was used for
further investigation in light of its CHM traditional use in
lung disease therapy.
Our study reveals that Formula 14 decreased the in
vitro tumorigenesis of A549 cells. The A549 lung cancer
cell line has been used widely for decades and has stable
tumorigenicity. Here, however, cells treated with FormulaEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: CHM Formula 14 led to A549 cells arrested in G0/G1 and G2 phase. Cell cycle analysis of A549 cells after treatment with Formula
14. (a) Representative data of cell cycle distribution proﬁle under Formula 14 treatment. Treatment with Formula 14 led to signiﬁcant cell
cyclearrestinG1andG2phase.(b)Quantiﬁedresultofcellsatdiﬀerentphasesfrom(a).(c)Representativedataofki67analysisofA549cells
after a 72hr treatment of Formula 14. (d) Fraction of cells in G0 and other phases. Formula 14 signiﬁcantly increased the G0 cell population
after 72hr treatment. Student’s t-test: ∗, ∗∗, ∗∗∗P<0.05, 0.01, and 0.001, respectively.
14 showed signiﬁcantly reduced colony formation in both
media and soft agar over long culture periods (14–30 days)
compared to the control cells.Human lung tumor xenografts
in immunosuppressed mice will be conducted in future to
explore the in vivo antitumorigenic eﬀects of Formula 14
treatment.
The growth of A549 cells was signiﬁcantly reduced by
Formula 14 treatment, which could be a result of either
inhibiting proliferation or increasing cell death. We suggest
thatthecellgrowthreductionbyFormula14-treatmentmust
be attributed to a speciﬁc inhibition of cell proliferation
rather than induction of apoptosis. The annexin V and
PI double staining experiments showed that Formula 14
treatment did not inﬂuence the A549 cell distribution in
normal (both annexin V and PI negative), early apoptotic
(annexin V positive and PI negative), and late apoptotic
or necrotic (both annexin V and PI positive) populations.
Fewer than 2% of cells were distributed in the early or late
apoptosispopulations.Inaddition,theA549cellcycleproﬁle
obtained from the PI staining revealed there was no subG18 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Western blots of the G1/S and G2/M regulatory proteins in A549 cells after 72hr treatment of Formula 14. (a) Examination of
A549 G1/S regulatory protein levels after treatment with Formula 14 for 72hr. The expression levels of cyclin D3, CDK4, and CDK6 and the
phosphorylation of Rb were signiﬁcantly decreased after treatment with Formula 14. (b) Western blots of cyclin B1, phosphorylated cdc2,
and total cdc2. The expression levels of cyclin B1 and the phosphorylation of cdc2 were decreased, while the expression of cdc2 was increased
after treatment with Formula 14. Results of 3 independent experiments were shown at the same time to show the consistent results. Student’s
t-test: ∗P<0.05. (n = 3).
(apoptotic) cell population. All of these observations suggest
that Formula 14 did not induce apoptosis in A549 cells.
Indeed, the cell cycle analyses showed that both G1 and
G2 phase arrest were induced in A549 cells by Formula 14.
These data together explain why Formula 14 suppressed the
cell growth without causing the cell death. We also noticed
signiﬁcant G1 arrest in cells treated with Formula 14 for only
24hr,whileG2arrestwasnotevidentuntil72hrhadelapsed.
We also examined the expression levels of regulators
involved in the cell cycle. Substantial decline of the G1/S
regulatory proteins (cyclin D3, CDK4, and CDK6) was
identiﬁed by Western blot analysis, which is in accordance
with the G1 arrest results obtained from cell cycle analysis.
We found that the phosphorylation of Rb (Ser807/811) was
alsodownregulatedaftertreatment.Rbisatumorsuppressor
protein that regulates cell proliferation by controlling pro-
gression through the G1 restriction point of the cell cycle.
Phosphorylation by cyclin D-CDK4/6 and cyclin E-CDK2
causes Rb inactivation, thus allowing cell cycle progression
[21–23]. Our result indicates that levels of these critical
regulators involved in G1/S promotion were severely reduced
by Formula 14.
However, Formula 14 seemed to have a more compli-
cated eﬀect toward G2/M cell cycle regulation. Formula 14
treatment decreased not only the expression of cyclin B1 but
also the Tyr-15 phosphorylated (pY15) form of cdc2. Cell
cycle G2/M progression is regulated by the cdc2-cyclin B1
kinase complex and is maintained in an inactive form by
phosphorylation at Thr14/Tyr15 of cdc2 [24]. Entry into the
M - p h a s eo ft h ec e l lc y c l ei sr e g u l a t e db ya c t i v a t i o no fc d c 2
kinase through cyclin B1 binding and dephosphorylation
of cdc2 at Thr14/Tyr15 [25, 26]. Although the level of
Tyr15-p-cdc2 was reduced by Formula 14, which would
tend to promote the G2/M progression, the severe reduction
of cyclin B1 would tend to decrease the formation of
cyclin B1-cdc2 complex. We suggest that the accumulationEvidence-Based Complementary and Alternative Medicine 9
O
D
5
7
0
0
0.5
1
1.5
2
2.5
02468 1 0
Conc. (%)
(a)
O
D
5
7
0
0
0.5
1
1.5
2
2.5
02468 1 0
Conc. (%)
(b)
Colony forming assay
Control F14
C
o
l
o
n
y
 
n
u
m
b
e
r
0
20
40
60
80
100
120
140
160
180
C
o
n
t
r
o
l
C
o
n
t
r
o
l
F
o
r
m
u
l
a
 
1
4
(c)
C F14
CDK4
Actin
pRb
Actin
Cyclin B1
Actin
C F14 C F14
(d)
Figure 6: The eﬀect of Formula 14 on NSCLC cell lines H460 and H520. Survival rate of H460 (a) and H520 (b) cells following treatment
with Formulae14 for 72hr was analyzed by MTT assay. (c) Formula 14 decreased the colony formation activity of H460 cells. Cell colonies
were stained with crystal violet and scanned to generate images. Colony numbers of those cells treated with Formula 14 (lower panel) were
signiﬁcantly decreased. (d) Western blots of the cell cycle regulatory proteins in H520 cells after 72hr treatment of Formula 14. Results of 3
independent experiments were shown at the same time to show the consistent results.10 Evidence-Based Complementary and Alternative Medicine
of cells in G2/M after Formula 14 treatment for 72hr
might be caused by the profound reduction of cyclin B1.
We suspect that diﬀerent ingredients in Formula 14 have
diﬀerent targets toward the cell cycle, which will need further
investigation.
To further investigate whether Formula 14 has a general
eﬀect toward NSCLC cell lines, we examine the viability
of another two NSCLC cell lines, H460 and H520, after
treatment with Formula 14. The study showed that IC50 of
thesetwocelllinesweresmallerthanthatofA549cells,which
suggest Formula 14 could inhibit the growth of H460 and
H520 eﬀectively. Results of colony-forming and Western blot
analyses further provide the evidence that Formula 14 could
suppress the tumorigenicity and cell cycle progression activi-
ties of H460 and H520 cells. Based on these observations, we
conclude that Formula 14 has similar eﬀect on NSCLC cell
lines.
Formula 14 is the standard formulation of Gui-Zhi-
Tang with the addition of Scutellariae baicalensis to create
another formula known as Yang-Dan-Tang. It was recently
reported that the crude ethanolic extracts of Scutellariae
baicalensis were selectively toxic to human lung cancer cell
lines [27]. Several investigations on constituent herbs of For-
mula 14 have revealed several pure compounds possessing
various biological activities. Isoliquiritigenin isolated from
Glycyrrhizae uralensis has been shown to induce apoptosis in
colorectal cancer cell lines [28]. Baicalein, baicalin, oroxylin
A, and wogonin are eﬀective compounds from Scutellariae
baicalensis and were identiﬁed to have antiproliferation
and proapoptosis ability [29–32]. Crude extracts of Fructus
Zizyphi Jujubae and Rhizoma Zingiberis were shown to
block angiogenesis [33] and enhance paclitaxel sensitivity
[34], respectively. Water extract of Paeoniae Rubrae was
also reported to have apoptotic eﬀect on hepatocellular
carcinoma cells [35]. In our study, we found Formula 14
could induce cell cycle arrest, as several previous reports
also show; however, we did not observe obvious apoptosis
of A549 cells after treatment with the formula. One possible
explanation is there might be interaction between diﬀerent
herb constituents of this formula which could lead to
complicated eﬀects.Anotherfactorthatmightaﬀecttheherb
eﬀects is serum concentration in the growth media. Most
studies observed apoptotic events when using a low serum
(0∼5%) condition [36–38], whereas we used a higher serum
(10%) condition in this study, which could provide stronger
survival signals or, alternatively, generate a stronger serum
binding eﬀect to compromise the herb eﬀects. On the other
hand, Formula 14 could not induce apoptosis but arrest cells
at G1/G2 phases of cell cycle, suggesting a cytostatic activity
for lung tumor. The signiﬁcance of cytostasis in anticancer
drug activity drew more attention as drug development
eﬀorts have moved from conventional chemotherapy to tar-
get therapy. However, it is suggested that a prolonged arrest
in a cell cycle stage other than G0 is intolerable to a cell and
must be resolved by either initiating a cell death or escaping
from the cell-cycle block [39]. Therefore, it is important
to examine the issue whether a continuous long-term
administration of Formulas 14 could have tumor-shrinkage
eﬀect in the further investigation with xenograft mouse
model.
5. Conclusion
We identiﬁed 3 potential formulae that could substantially
decrease the survival of NSCLC cells while not aﬀecting
MRC5 normal lung cells. Formula 14, the Yang-Dan-
T a n g ,w a sc h o s e nf o rf u r t h e rs t u d yf o ri t se ﬀect on cell
growth suppression. A colony-forming assay demonstrated
that Formula 14 has antitumorigenic activity. In addition,
ﬂow cytometry showed that Formula 14 induced cell cycle
arrest in G1 and G2 phase without causing signiﬁcant cell
death. This result was further conﬁrmed by western blot
analysis which showed reduced expression of G1/S and
G2/M regulators. Our study provides further insight into
the working mechanism of Chinese medicine formulae in
patients.
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